References
Coussens, L.M., W. W. Raymond, G. Bergers, M. Laig-Webster, O. Behrendtsen, Z. Werb. G. H. Caughey & D. Hanahan (1999) Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13: 1382–1397
Gerber, H.-P., T. H. Vu, A.M. Ryan. J. Kowalski, Z. Werb & N. Ferrara (1999) VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nature Med. 5:623–628
Stemlicht, M. D., A. Lochter, C. J. Sympson, B. Huey, J.-P. Rougier, J. W. Gray, D. Pinkel, M. J. Bissell & Z. Werb (1999) The stromal proteinase MMP-3/stromelysin-1 promotes mammary carcinogenesis. Cell. 98:137–146
Bergers. G., R. Brekken, G. McMahon, T.H. Vu, T. Itoh, K. Tamaki, K. Tanzawa, P. Thorpe, S. Itohara, Z. Werb & D. Hanahan (2000) Matrix metalloprotcinase-9 triggers the angiogenic switch during carcinogenesis. Nature Cell Biol. 2:737–744
Coussens, L. M., C. L. Tinkle, D. Hanahan & Z. Werb (2000) MMP-9 supplied by bone marrow-derived cells regulates skin carcinogenesis. Cell. 103:481–490
Engsig, M.T., Q.-J. Chen, T. H. Vu, A.C. Pedersen, B. Therkidsen, L. Lund, K. Henriksen, B. Winding, T. Lenhard, N. T. Foged, Z. Werb & J.-M. Delaisse (2000) Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J. Cell Biol. 151:879–890
Liu, Z., X. Zhou, S. D. Shapiro, J. M. Shipley, L. A. Dias, R. M. Senior & Z. Werb (2000) α1-proteinase inhibitor is the critical substrate for ge1atinase B/ MMP-9 in vivo. Cell. 102:647–655
Stemlicht, M.D. & Z. Werb (2001) How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17:463–516
Egeblad, M. & Z. Werb (2002) New functions for the matrix metalloproteinases in cancer progression. Nature Rev. Cancer. 2:163–176
Heissig, B., K. Hattori, S. Dias, B. Ferris, M. Friedrich, N. R. Hackett, D. Lyden, J. Wood, R. G. Crystal, M.A.S. Moore, Z. Werb & S. Rafii (2002) Mobilization of stem cells from the bone marrow niche requires MMP-9-mediated release of Kit ligand. Cell (in press)
Rights and permissions
About this article
Cite this article
14th Pezcoller Symposium: The Novel Dichotomy of Immune Interactions with Tumors 30 May–1 June 2002, Trento, Italy. Cancer Immunol Immunother 51, 397–408 (2002). https://doi.org/10.1007/s262-002-0291-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s262-002-0291-5